A systematic review of medical interventions for oral submucous fibrosis and future research opportunities


  • This manuscript is part of the outcomes of the World Workshop on Oral Medicine V. (2010)

Professor Saman Warnakulasuriya, Department of Oral Medicine, King’s College London Dental Institute, Denmark Hill Campus, Caldecot Road, London SE5 9RW, UK. Tel: +44 20 3299 2430, Fax: 44 203 299 3624, E-mail: s.warne@kcl.ac.uk


Oral Diseases (2011) 17 (Suppl. 1), 42–57

Oral submucous fibrosis (OSF) is a chronic, insidious disease caused by areca nut use, and is associated with both significant morbidity (including pain and reduced oral opening) and an increased risk for malignancy. This systematic review explored and updated the current medical (i.e., non-surgical) interventions available for the management of OSF. Of the 27 published medical interventions, there were four randomized controlled trials. The overall quality of these randomized controlled studies was assessed using the GRADE approach and significant limitations that challenged the conclusions were found. However, this review was valuable in terms of identifying opportunities to provide recommendations for future research, in terms of the populations to research, the types of interventions needed, the types of outcomes to be measured, the study designs needed, and the infrastructure required to conduct studies. The next step is to initiate a pathway for a low-cost research plan leading to the development of a brief protocol for future clinical trials in this field, with an emphasis on conducting studies in regions of the world where OSF is prevalent.